Actively Recruiting
Prognostic Value of BNP in MCS - a 25 Year Follow up Study
Led by Rigshospitalet, Denmark · Updated on 2021-05-05
1000
Participants Needed
1
Research Sites
1297 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy. Patients will be followed up for 25 years after inclusion.
CONDITIONS
Official Title
Prognostic Value of BNP in MCS - a 25 Year Follow up Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark
- Age >18 years
You will not qualify if you...
- No consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rigshospitalet
Copenhagen, DK, Denmark, 2100
Actively Recruiting
Research Team
K
Kiran Mirza, MD
CONTACT
F
Finn Gustafsson, MD, PhD, DMSci
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here